This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies on Taiwan, based on in-depth interviews conducted with leaders and pioneers across the value chain, from government representatives, global affiliate heads, and founders of innovative local SMEs.

While Taiwan’s remarkable economic growth has largely been due to a perspicacious early embrace of the semi-conductor industry; Taiwanese healthcare and life sciences, especially biotechnology, is fast gaining in importance and acquiring a global reputation. President Tsai Ing-wen herself has a background in biosciences, and many of the companies and institutions featured in the report are positioned at the vanguard of new innovations and technology in pharmaceuticals and biotech.